Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
52.99
+1.47 (2.85%)
At close: Sep 18, 2025, 4:00 PM EDT
53.69
+0.70 (1.32%)
After-hours: Sep 18, 2025, 6:42 PM EDT
Bio-Techne Employees
Bio-Techne had 3,100 employees as of June 30, 2025. The number of employees did not change compared to the previous year.
Employees
3,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$393,431
Profits / Employee
$23,665
Market Cap
8.24B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 3,100 | 0 | - |
Jun 30, 2024 | 3,100 | 50 | 1.64% |
Jun 30, 2023 | 3,050 | 50 | 1.67% |
Jun 30, 2022 | 3,000 | 400 | 15.38% |
Jun 30, 2021 | 2,600 | 300 | 13.04% |
Jun 30, 2020 | 2,300 | 50 | 2.22% |
Jun 30, 2019 | 2,250 | 250 | 12.50% |
Jun 30, 2018 | 2,000 | 200 | 11.11% |
Jun 30, 2017 | 1,800 | 240 | 15.38% |
Jun 30, 2016 | 1,560 | 204 | 15.04% |
Jun 30, 2015 | 1,356 | 335 | 32.81% |
Jun 30, 2014 | 1,021 | 167 | 19.56% |
Jun 30, 2013 | 854 | 7 | 0.83% |
Jun 30, 2012 | 847 | 13 | 1.56% |
Jun 30, 2011 | 834 | 97 | 13.16% |
Jun 30, 2010 | 737 | -9 | -1.21% |
Jun 30, 2009 | 746 | 27 | 3.76% |
Jun 30, 2008 | 719 | 38 | 5.58% |
Jun 30, 2007 | 681 | 44 | 6.91% |
Jun 30, 2006 | 637 | 28 | 4.60% |
Jun 30, 2005 | 609 | 12 | 2.01% |
Jun 30, 2004 | 597 | 11 | 1.88% |
Jun 30, 2003 | 586 | 16 | 2.81% |
Jun 30, 2002 | 570 | 9 | 1.60% |
Jun 30, 2001 | 561 | 64 | 12.88% |
Jun 30, 2000 | 497 | 26 | 5.52% |
Jun 30, 1999 | 471 | 60 | 14.60% |
Jun 30, 1998 | 411 | 46 | 12.60% |
Jun 30, 1997 | 365 | -7 | -1.88% |
Jun 30, 1996 | 372 | 28 | 8.14% |
Jun 30, 1995 | 344 | 67 | 24.19% |
Jun 30, 1994 | 277 | 71 | 34.47% |
Jun 30, 1993 | 206 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TECH News
- 8 days ago - Bio-Techne Corporation (TECH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 9 days ago - Bio-Techne Corporation (TECH) Presents At Baird Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 9 days ago - ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California - PRNewsWire
- 15 days ago - Bio-Techne Corporation (TECH) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 22 days ago - Bio-Techne to Present at Upcoming Investor Conferences - PRNewsWire
- 5 weeks ago - ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory - PRNewsWire
- 6 weeks ago - Bio-Techne Corporation (TECH) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Bio-Techne beats quarterly estimates on strength in protein sciences unit - Reuters